Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;62(4):730-7.
doi: 10.1053/j.ajkd.2013.02.373. Epub 2013 May 10.

Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study

Ioannis Koulouridis  1 , Mansour Alfayez, Hocine Tighiouart, Nicolaos E Madias, David M Kent, Jessica K Paulus, Bertrand L Jaber
Affiliations

Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study

Ioannis Koulouridis et al. Am J Kidney Dis. 2013 Oct.

Abstract

Background: Case series suggest that long-term use of proton pump inhibitors (PPIs) is associated with hypomagnesemia, but the current literature lacks systematically collected data. Our aim was to examine whether hypomagnesemia at the time of hospital admission is associated with out-of-hospital use of PPIs.

Study design: Nested case-control study matched for age and sex.

Setting & participants: Data were collected retrospectively from a tertiary acute-care facility. Eligible cases consisted of 402 adults with hypomagnesemia (serum magnesium <1.4 mEq/L) at the time of hospital admission to medical services, age- and sex-matched with 402 control individuals with normal serum magnesium levels (1.4-2.0 mEq/L).

Predictor: Out-of-hospital PPI use was identified in the hospital record. An omeprazole equivalent dose was calculated when possible. Covariates included the Charlson-Deyo comorbidity index, diabetes, diuretic use, estimated glomerular filtration rate, and gastroesophageal reflux.

Outcome: Multivariable conditional logistic regression analyses were used to examine the association of PPI use with hypomagnesemia at the time of hospital admission.

Results: PPI use was not associated with hypomagnesemia (adjusted OR, 0.82; 95% CI, 0.61-1.11). Neither PPI type nor omeprazole equivalent daily dose was associated with hypomagnesemia. Sensitivity analyses of PPI use restricted to patients with esophageal disorders (adjusted OR, 1.00; 95% CI, 0.69-1.45), severe hypomagnesemia (magnesium, ≤1.0 mEq/L; adjusted OR, 0.78; 95% CI, 0.13-4.61), or estimated glomerular filtration rate ≥60 mL/min/1.73 m(2) (adjusted OR, 0.84; 95% CI, 0.53-1.34) were unrevealing.

Limitations: Exposure misclassification; hospitalized patients on medical services may not be representative of a broader ambulatory-based population.

Conclusions: In a hospital-based adult population, out-of-hospital PPI use is not associated with hypomagnesemia at the time of hospital admission to medical services. In light of these inconclusive results, prospective cohort studies are needed to address this rare potential medication-related adverse effect.

Keywords: Hypomagnesemia; electrolyte disorders; proton pump inhibitors (PPIs).

PubMed Disclaimer

Conflict of interest statement

FINANCIAL CONFLICT OF INTEREST

Ioannis Koulouridis: None

Mansour Alfayez: None

Hocine Tighiouart: None

Nicolaos E. Madias: None

David M. Kent: None

Jessica K. Paulus: None

Bertrand L. Jaber: None related to this manuscript

Figures

Figure 1
Figure 1
Flow diagram describing the derivation of the analytical dataset.
See this image and copyright information in PMC

References

    1. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008 Oct;135(4):1383–1391. 1391 e1381–1391 e1385. - PubMed
    1. Bader JP, Delchier JC. Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther. 1994;8(Suppl 1):47–52. - PubMed
    1. U S Food and Drug Administration. [Accessed in February 2012];2010 May 25; URL: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm213240.htm.
    1. Pasina L, Nobili A, Tettamanti M, et al. Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors: analysis of prescriptions. Int J Clin Pharmacol Ther. 2010 Nov;48(11):735–743. - PubMed
    1. Fendrick AM, Shaw M, Schachtel B, et al. Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn. Clin Gastroenterol Hepatol. 2004 Jan;2(1):17–21. - PubMed

Publication types

Substances

Supplementary concepts

LinkOut - more resources